This concept of ‘reserve’ emerged due to individual differences in the susceptibility of cognitive impairment as well as discontinuity between cognitive outcomes and neuropathology (e.g., β-amyloid burden & neurofibrillary tangles of Tau) [31,79]. The gene discussed is MAPT; the disease is Cognitive impairment.